Rasawone Tablet 0.5 mg (Rasagiline Mesylate)

Adult dose

This medicine is administered orally to adults once daily as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy with a dopamine agonist: Administer 1mg orally once daily. 2) Adjunctive therapy with levodopa: The recommended initial dose for patients taking levodopa is 0.5mg once daily. If well tolerated and the clinical response is insufficient, the dose may be increased to 1mg once daily. This medicine may be taken with or without food.

This medication should not be administered to specific patients. Individuals allergic to the main ingredient or other components should avoid taking it. Additionally, this medication should not be used in individuals currently taking or who have recently stopped taking other MAO inhibitors or certain natural medicines. Particularly, individuals taking or who have recently stopped taking medications such as pethidine, tramadol, or dextromethorphan should not take this medication. It is also safer not to use this medication in patients with moderate to severe liver dysfunction. Taking this medication can result in various side effects. Commonly reported side effects include headache, dizziness, nausea, insomnia, skin rash, joint pain, muscle pain, and changes in blood pressure. Additionally, psychiatric symptoms such as hallucinations and depression may occur, necessitating caution. Serious symptoms such as movement disorders or hypotension can also arise, requiring immediate consultation with a physician in case of abnormal symptoms. This medication has many drug interactions, so it is essential to consult with healthcare professionals about other medications being taken. Especially, when combined with other MAO inhibitors, specific analgesics, antidepressants, cold medications, or sympathomimetics, serious side effects may occur. Furthermore, smokers should be cautious as the effects of this medication may be reduced. Women who are pregnant have limited experience with this medication, so caution is required; similarly, nursing mothers should use it cautiously as the medication can be transmitted through breast milk. This medication has not established safety and efficacy in children under 18 years of age, and no dose adjustment is required for elderly patients over 65 years of age. In cases of overdose, serious symptoms such as hypertension, mania, and serotonin syndrome may occur, necessitating immediate treatment at a medical institution. This medication should be stored out of reach of children, in a cool temperature (1-25 degrees Celsius), and should not be transferred to another container.

• Influenza
• skin cancer
• leukopenia
• allergies
• loss of appetite
• depression
• hallucinations
• headache
• cerebrovascular accident
• conjunctivitis

This medication should be stored in a sealed container to prevent exposure to air or moisture, and the appropriate storage temperature is a cool place between 1 and 25 degrees Celsius.

Appearance

White round tablet

Package unit

30 tablets/bottle